Sorrento Therapeutics News Releases

Sorrento Therapeutics, Inc. Receives Court Approval for $75 Million Financing in Chapter 11 Case

about 2 years ago

SAN DIEGO , Feb. 21, 2023 /PRNewswire/ -- Sorrento Therapeutics, Inc. (Nasdaq...

Sorrento Posts Form 8937 to Supplement its Previously Issued “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock (Nasdaq: SCLX, “Scilex”)

about 2 years ago

SAN DIEGO , Feb. 18, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc...

Sorrento Issues Update to its Previously Issued “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock (Nasdaq: SCLX, “Scilex”)

about 2 years ago

SAN DIEGO , Feb. 17, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc...

Sorrento Therapeutics, Inc. Receives Court Approval for "First Day" Employee Wages and Cash Management Motions

about 2 years ago

SAN DIEGO , Feb. 16, 2023 /PRNewswire/ -- Sorrento Therapeutics, Inc. (Nasdaq...

Report of Organizational Actions Affecting Basis of Securities

about 2 years ago

Joint Statement by Sorrento Therapeutics, Inc. and Scilex Holding Company on Today’s Isolated Chapter 11 Filing By Sorrento Therapeutics, Inc.

about 2 years ago

SAN DIEGO and PALO ALTO, Calif. , Feb. 13, 2023 (GLOBE NEWSWIRE)...

Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., Announces Record and Meeting Dates for its first Annual Meeting of Stockholders

over 2 years ago

PALO ALTO, Calif. , Feb. 04, 2023 (GLOBE NEWSWIRE) -- Scilex Holding...

Sorrento Distributes Dividend Confirmation Statements to 146 Brokerage Firms and Provides Specific Instruction to Continental Stock Transfer & Trust Company Regarding the Dividend of Scilex Holding Company Common Stock

over 2 years ago

SAN DIEGO , Feb. 03, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc...

Sorrento Issues Supplement to its Previously Issued “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock

over 2 years ago

SAN DIEGO , Feb. 02, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc...

Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued a Supplement to its Previously Issued “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock

over 2 years ago

PALO ALTO, Calif. , Feb. 02, 2023 (GLOBE NEWSWIRE) -- Scilex Holding...

Sorrento Issues “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock

over 2 years ago

SAN DIEGO , Jan. 29, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics...

Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued an “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock

over 2 years ago

PALO ALTO, Calif. , Jan. 29, 2023 (GLOBE NEWSWIRE) -- Scilex Holding...